Adimanebart IV

BIOLOGICAL2 trials

Sponsors

argenx

Conditions

CMSCongenital Myasthenic SyndromeHealthy VolunteerHealthy Volunteers (HV)

Phase 1

A Study to Assess the Absolute Bioavailability and How Adimanebart SC Moves Through the Body in Healthy Adult Participants

RecruitingNCT07673601

argenxHealthy Volunteer, Healthy Volunteers (HV)

Start: 2026-06-12End: 2026-12-01Target: 52Updated: 2026-06-29

Phase 3

A Study to Assess Efficacy and Safety of Adimanebart in Adult and Pediatric Participants With DOK7-,MUSK-, AGRN-, or LRP4- Congenital Myasthenic Syndromes (CMS)

Not yet recruitingNCT07746089

argenxCMS, Congenital Myasthenic Syndrome

Start: 2026-09-01End: 2030-10-01Target: 105Updated: 2026-08-04